Go to main content
United Kingdom
HCP LOG IN / SIGN IN
Product Overview

Portfolio AOP Health

 Product overview with focus on integrated therapies for rare diseases and in critical care.

Product Overview

AOP Health's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

Following products are currently available in the UK.

AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.

Intensive Care

Argipressin AOP

Argipressin AOP is used to treat diabetes insipidus and bleeding from enlarged veins in the oesophagus.

Drug Facts
Active Ingredient
Argipressin
Intensive Care

Esmolol®

Esmolol® is indicated for supraventricular tachycardia and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.

Drug Facts
Active Ingredient
Esmolol Hydrochloride
Intensive Care

Naloxone

Naloxone hydrochloride is for complete or partial reversal of CNS and especially respiratory depression, caused by natural or synthetic opioids.

Drug Facts
Active Ingredient
Naloxone Hydrochloride Dihydrate